Susquehanna International Group’s Dianthus Therapeutics DNTH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $560K | Sell |
30,067
-17,311
| -37% | -$323K | ﹤0.01% | 4160 |
|
|
2025
Q1 | $859K | Buy |
47,378
+30,856
| +187% | +$560K | ﹤0.01% | 3581 |
|
|
2024
Q4 | $360K | Buy |
+16,522
| New | +$360K | ﹤0.01% | 4509 |
|
|
2024
Q2 | – | Sell |
-205,487
| Closed | -$6.16M | – | 5834 |
|
|
2024
Q1 | $6.16M | Buy |
205,487
+176,808
| +617% | +$5.3M | ﹤0.01% | 903 |
|
|
2023
Q4 | $298K | Buy |
+28,679
| New | +$298K | ﹤0.01% | 4537 |
|
|
2023
Q3 | – | Sell |
-6,456
| Closed | -$78.3K | – | 5725 |
|
|
2023
Q2 | $78.3K | Sell |
6,456
-4,888
| -43% | -$59.3K | ﹤0.01% | 5093 |
|
|
2023
Q1 | $144K | Buy |
+11,344
| New | +$144K | ﹤0.01% | 5068 |
|
|
2022
Q3 | – | Sell |
-2,873
| Closed | -$55K | – | 6277 |
|
|
2022
Q2 | $55K | Buy |
+2,873
| New | +$55K | ﹤0.01% | 5210 |
|
|
2022
Q1 | – | Sell |
-652
| Closed | -$46K | – | 5897 |
|
|
2021
Q4 | $46K | Buy |
+652
| New | +$46K | ﹤0.01% | 5486 |
|
|
2021
Q3 | – | Sell |
-1,288
| Closed | -$201K | – | 5477 |
|
|
2021
Q2 | $201K | Sell |
1,288
-397
| -24% | -$62K | ﹤0.01% | 4836 |
|
|
2021
Q1 | $319K | Buy |
1,685
+775
| +85% | +$147K | ﹤0.01% | 4304 |
|
|
2020
Q4 | $114K | Sell |
910
-289
| -24% | -$36.2K | ﹤0.01% | 4457 |
|
|
2020
Q3 | $130K | Buy |
+1,199
| New | +$130K | ﹤0.01% | 4036 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 4354 |
|
|
2019
Q4 | – | Sell |
-664
| Closed | -$109K | – | 4163 |
|
|
2019
Q3 | $109K | Buy |
+664
| New | +$109K | ﹤0.01% | 4063 |
|